FDA Okays Pill Version Of Weight Loss Drug Wegovy
STAT News reports: The Food and Drug Administration today approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to be cleared by regulators for obesity and possibly allowing many more Americans to access a highly effective treatment. The Wegovy pill, whose approval for weight loss was […]
First GLP-1 weight-loss pill on sale in the US within weeks for $149 a month
The next transformative phase of weight-loss medication is upon us, with the US Food and Drug Administration (FDA) approving Novo Nordisk’s highly anticipated oral GLP-1 drug – with a starting dose available in early January for US$149. Continue Reading Category: Obesity, Illnesses and conditions, Body and Mind Tags: Novo Nordisk, Eli Lilly, Ozempic, clinical trials, […]
The Daily Market Flux – Your Complete Market Rundown (12/23/2025)
Our platform aggregates and organizes all relevant market news, helping you stay informed, up-to-date, and knowledgeable without spending hours sifting through headlines. Reinvented to keep you in control, it’s where your edge begins with better information. Go from market noise to clarity in seconds with a real-time platform built to redefine how traders and investors […]
Internet divided as Chipotle unveils new GLP-1 menu options
The announcement has not been a hit with everyone. While some were excited, many people on the internet have roasted the fast food chain over it.
CMS shares GLP-1 model: 7 notes
CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. The announcement comes weeks following the White House’s agreements with Eli Lilly and Novo Nordisk to apply most-favored-nation pricing for drugs that treat obesity, diabetes and related conditions. “Today’s announcement builds upon our […]
US Health Agency to Expand Access to GLP-1 Weight-Loss Drugs
Dec 23 (Reuters) – The U.S. Centers for Medicare and Medicaid Services said on Tuesday it will negotiate drug pricing with manufacturers…
S&P 500 surges to record after strong US economic report
The S&P 500 finished up 0.5% at 6,909.79, narrowly topping a record set earlier this month. (EPA Images pic) NEW YORK: The S&P 500 powered to a fresh record Tuesday following data showing surprisingly robust third-quarter US economic growth as markets hope for a year-end “Santa Claus Rally”. All three major Wall Street indices advanced, […]
Tirzepatide Synergizes with Leptin on Weight Loss and Restoring Metabolic Homeostasis in Diet-induced Obesity Model
Leptin resistance limits anti-obesity efficacy. We identified a leptin-sensitizing mechanism through tirzepatide (TZP), a glucagon-like peptide-1 receptor (GLP-1R) and glucose-dependent insulinotropic polypeptide receptor (GIPR) dual-agonist. Our tirzepatide clinical trial revealed that circulating leptin levels at baseline correlated with weight loss efficacy in patients with obesity, suggesting leptin and tirzepatide could interact to achieve stronger effects […]
美国卫生机构将就GLP-1减肥药价格展开谈判
US health agency to negotiate prices for GLP-1 weight-loss drugs (www.reuters.com) 06:10
US Economy Expands 4.3 Percent in Third Quarter, Topping Expectations
The Commerce Department reported that the U.S. economy grew 4.3 percent in the third quarter, topping expectations. NTD looks at what drove the uptick. A significant change in America’s skies. The Federal Communications Commission is planning to ban the next generation of Chinese-made drones, citing them as a national security risk. The Food and Drug […]